Introduction
Hyperornithinemia-hyperammonemia-homocitrullinuria (HHH) syndrome (OMIM 238970) is an autosomal recessive disorder due to mutation in the gene that encodes the mitochondrial ornithine (Orn) transporter ORNT1 (SLC25A15) (Camacho et al., 1999; Fell et al., 1974; Korman et al., 2004; Tessa et al., 2009; Valle and Simell, 2001) . The inability to import Orn from the cytosol into the mitochondria results in intramitochondrial Orn deficiency and a functional impairment of the urea cycle at the level of ornithine transcarbamylase, with consequent hyperammonemia. The defect also gives rise to cytoplasmatic accumulation of Orn resulting in hyperornithinemia. In the absence of intramitochondrial Orn, accumulating carbamoyl phosphate may condense with lysine to form homocitrulline (Hcit) leading to homocitrullinuria (Valle and Simell, 2001) . The clinical features of neurological symptoms in HHH syndrome are very peculiar since, besides some unspecific signs similar to the others urea cycle defects (hypotonia, seizures, ataxia, coma, etc.) , patients exhibit a pyramidal syndrome with progressive spastic paraplegia. Neuropathological findings include multiple, nonspecific T2 hyperintense foci in occipital, parietal and frontal white matter, with subcortical and cortical atrophy associated with swelling typically seen in demyelinating diseases (Al-Hassnan et al., 2008) . It should be stressed that among the urea cycle defects, pyramidal dysfunction is also present in argininemia and therefore both disorders share a common characteristic clinical picture (Valle and Simell, 2001) .
The mechanisms of central nervous system (CNS) impairment in HHH syndrome are poorly known (Palmieri, 2008; Salvi et al., 2001) , although it has been hypothesized that the neurologic damage presented by the patients are probably secondary to the episodic hyperammonemia. However, chronic accumulation of Orn, Hcit and other metabolic factors cannot be ruled out as contributing causes of the neurological symptoms and brain abnormalities seen in these patients, especially during crises of metabolic decompensation, in which the concentrations of these metabolites dramatically increase. It seems therefore justifiable to investigate the role of these accumulating metabolites on important systems necessary for normal CNS function that may lead to a better understanding of the relationship between the clinical features and the biochemical abnormalities in this disorder.
In this scenario, we have recently demonstrated that Orn and Hcit elicit in vitro lipid peroxidation, protein oxidative damage and decrease glutathione (GSH) levels and disrupt energy metabolism in brain of young rats Viegas et al., 2009) .
In the present study we investigated whether in vivo intracerebroventricular (ICV) administration of Orn and Hcit to rats could induce lipid (thiobarbituric acid-reactive substances) and protein (sulfhydryl content and carbonyl formation) oxidative damage, as well as affect the antioxidant defenses (reduced glutathione levels and the activities of the antioxidant enzymes glutathione peroxidase, catalase and superoxide dismutase) and nitrates and nitrites production. We also tested the influence of in vivo ICV administration of these amino acids on parameters of aerobic glycolysis (CO 2 production from [U-14 C] glucose), citric acid cycle (CAC) activity (CO 2 production from [1-14 C] acetate and the enzyme activities of the CAC), electron transfer flow through the respiratory chain (complex I-IV activities), as well as on intracellular ATP transfer (creatine kinase activity) and the activity of Na + , K + -ATPase, an important enzyme necessary for normal neurotransmission, in cerebral cortex from young rats.
Results

2.1.
Oxidative stress parameters
Orn and Hcit intracerebroventricular administration induces lipid peroxidation in cerebral cortex
Initially we studied the effect of intracerebroventricular (ICV) injection of Orn and Hcit on TBA-RS levels in cerebral cortex. Fig. 1A shows that Orn (37%) and Hcit (43%) induced lipid peroxidation (TBA-RS increase) in cerebral cortex 30 min after drug infusion [F(2,16) = 6.671; p < 0.01]. Next, we examined the effect of i.p. daily injections of N-acetylcysteine (NAC: 150 mg/kg), α-tocopherol (40 mg/kg) plus ascorbic acid (100 mg/kg), or saline (0.9% NaCl) for 3 days (pretreatment), on Orn and Hcit-induced lipid oxidative damage. As shown in the figure, pre-treatment with NAC fully prevented the lipoperoxidation induced by Hcit, but only attenuated the lipid peroxidation caused by Orn. It can be also seen that pre-treatment with α-tocopherol plus ascorbic acid partially prevented the lipid peroxidation elicited by Orn and Hcit ( Fig. 1B and C 
Hcit intracerebroventricular administration inhibits enzymatic antioxidant defenses in cerebral cortex
The next set of experiments was carried out to investigate the effect of ICV administration of Orn and Hcit on the activities of the antioxidant enzymes SOD, CAT and GPx. Fig. 3 
Hcit intracerebroventricular administration inhibits aconitase activity in cerebral cortex
We also evaluated the effect of Orn and Hcit ICV administration on CAC enzyme activities. We found that Hcit, significantly inhibited (20%) aconitase activity (μmol NADPH min
: n = 6; control: 1339.4 ± 82.9; Orn: 1208.4 ± 135.6; Hcit: 1070.4 ± 96.9), [F(2,14)= 8.450, p < 0.01], whereas Orn did not alter this activity. Furthermore, citrate synthase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase, succinate dehydrogenase, and malate dehydrogenase activities were not changed by Orn and Hcit administration (results not shown).
Intracerebroventricular injection of Orn and Hcit inhibits complex I-III activity of the respiratory chain in cerebral cortex
The next set of experiments was performed to evaluate the effect of ICV injection of Orn and Hcit on the activities of the respiratory chain complexes I-III, II, II-III and IV. We found that complex I-III activity was significantly inhibited by Orn (20%) and Hcit (26%) [F(2,15) = 10.274; p < 0.01], with no significant alteration of the other tested activities of the respiratory chain (Table 1) .
Orn and Hcit intracerebroventricular administration does not alter creatine kinase and Na + , K + -ATPase activities in cerebral cortex
We also examined the effect of Orn and Hcit ICV administration on the activities of creatine kinase (CK) and synaptic membrane Na + , K + -ATPase prepared from cerebral cortex. We observed that these metabolites did not change these activities (CK: μmol creatine min −1 mg protein
: n = 7; control: 4.33 ± 0.81; Orn: 5.31 ± 0.97; Hcit: 4.48 ± 0.67; NaK: nmol Pi min −1 Fig. 3 -Effect of intracerebroventricular administration of ornithine (Orn) and homocitrulline (Hcit) on the activities of glutathione peroxidase (GPx), catalase (CAT) and superoxide dismutase (SOD) in rat cerebral cortex. Data are expressed as means ± standard deviation for six to seven independent experiments (animals). *p < 0.05 and **p < 0.01, compared to control (ANOVA followed by Duncan's multiple range test). Values are means ± standard deviation for five independent experiments (animals) per group and expressed as pmol CO 2 h − 1 g tissue − 1 . *p < 0.05 and **p < 0.01, compared to control (ANOVA followed by Duncan's multiple range test).
mg protein
: n = 4; control: 209.8 ± 71.7; Orn: 207.5 ± 42.2; Hcit: 258.3 ± 28.2).
Discussion
Patients affected by this HHH syndrome commonly have neurological dysfunction with acute encephalopathy, ataxia, choreoathetosis, developmental delay, severe muscle spasticity and mental retardation, whose neuropathology is poorly known (Shih et al., 1969; Valle and Simell, 2001) . Interestingly, patients with HHH syndrome and argininemia present similarities in clinical features, with progressive neurological deterioration and pyramidal signs that are usually not associated with hyperammonemic decompensation (Korman et al., 2004; Marescau et al., 1990; Salvi et al., 2001; Valle and Simell, 2001 ). Furthermore, it has been suggested that the lower limb dysfunction observed in HHH syndrome, and also in argininemia, may be related to an altered polyamine metabolism (Shimizu et al., 1990) .
On the other hand, many individuals with HHH syndrome present mitochondrial abnormalities, as well as accumulation and excretion of lactic acid, ketone bodies and CAC intermediates (Gatfield et al., 1975; Haust et al., 1981; Metoki et al., 1984; Salvi et al., 2001) , indicating an impaired mitochondrial function. Therefore, in the current study we evaluated the in vivo effects of these amino acids accumulating in HHH syndrome on important biochemical parameters of mitochondrial homeostasis, particularly those related to bioenergetics and biological oxidations in cerebral cortex of young rats in order to provide mechanistic insights for HHH syndrome neuropathology.
We first verified that Orn and Hcit in vivo administration to rats increased TBA-RS levels, as compared with control animals. These results corroborate our previous in vitro findings ). Since TBA-RS measurement reflects the amount of malondialdehyde formation, an end product of membrane fatty acid peroxidation (Halliwell and Gutteridge, 2007) , the increased values of this parameter elicited by Orn and Hcit strongly indicates that these amino acids caused lipid peroxidation in vivo.
Orn, and also Hcit to a higher degree, enhanced carbonyl formation, implying that they caused protein oxidation. In this scenario, carbonyl groups (aldehydes and ketones) are mainly produced by oxidation of protein side chains (especially Pro, Arg, Lys, and Thr), by oxidative cleavage of proteins, or by the reaction of reducing sugars or their oxidation products with lysine protein residues (Dalle-Done et al., 2003) . However, we cannot also exclude the possibility that aldehydes resulting from lipid peroxidation may also induce carbonyl generation (Dalle-Done et al., 2003) .
It was also observed that the antioxidants N-acetylcysteine (NAC), that forms glutathione intracellularly, and the combination of the free radical scavengers ascorbic acid plus α-tocopherol attenuated the lipid oxidation and totally prevented the protein oxidative damage provoked by Hcit, suggesting that ROS generation was involved in its effects. As regards to the reactive species involved in Orn and Hcit pro-oxidant effects, it is feasible that the peroxyl radical, which is scavenged by α-tocopherol whose active form is regenerated (reduced) by ascorbic acid, may underlie at least in part these oxidative effects. However, considering that NAC also prevented these effects, we cannot exclude the possibility that a shortage of GSH could be responsible for lipid and especially protein oxidative damage provoked by Hcit and Orn. In fact, we found that Hcit ICV administration gave rise to a decrease of GSH concentrations, besides significantly inhibiting the activity of the antioxidant enzymes CAT and GPx with no effect on SOD. In contrast, Orn did not significantly affect any of these antioxidant defenses. Furthermore, it is unlikely that reactive nitrogen species participated in the pro-oxidant effects of Orn and Hcit since these compounds did not elicit nitrate and nitrite synthesis. Considering that endogenous GSH is considered the major naturally occurring brain antioxidant and that GPx and CAT activities are important enzymatic antioxidant defenses (Halliwell and Gutteridge, 2007), we presume that the rat cortical antioxidant defenses were compromised by in vivo administration of Hcit. Furthermore, it is also conceivable that the reduction of GSH levels may reflect increased reactive species generation elicited by Hcit. In this context, it may be presumed that Orn did not reduce GSH levels probably because it induced less reactive species formation compared to Hcit, reflected by its lower oxidative effects.
Our present data strongly indicate that in vivo administration of the major amino acids accumulating in HHH syndrome induces oxidative stress in rat cerebral cortex since this deleterious cell condition results from an imbalance between the total antioxidant defenses and the reactive species generated in a tissue (Halliwell and Gutteridge, 2007) . It should be emphasized that the brain has low cerebral antioxidant defenses compared with other tissues (Halliwell and Gutteridge, 1996) , a fact that makes this tissue more vulnerable to increased reactive species.
With respect to the parameters of energy metabolism, Orn and Hcit compromised the aerobic glycolytic pathway and the CAC activity since they significantly decreased CO 2 formation from labeled glucose and acetate, respectively. It is therefore possible that Orn and Hcit may have inhibited the activity of one or more glycolytic enzymes, one or more reactions of the CAC, and/or the respiratory chain.
We did not determine the activities of the glycolytic pathway, but measured CAC enzyme activities and the activities of complexes I-IV of the respiratory chain following Orn and Hcit in vivo administration. Hcit significantly inhibited aconitase activity, without altering the other enzymes of the CAC, whereas Orn did not affect any of these activities. Considering that aconitase is highly vulnerable to oxidative damage (Gardner, 1997) and that Hcit provoked a higher degree of protein oxidative damage compared to Orn, it is possible that aconitase inhibition may have a result of Hcitinduced free radical attack to essential groups of the enzyme. Furthermore, Orn and Hcit significantly reduced the electron transport chain flow by inhibiting the activity of complex I-III. Thus, it is feasible that the inhibition of complex I-III activity by these metabolites and of aconitase by Hcit contributed to the inhibition of the CAC. Altogether, these findings indicate that brain bioenergetics associated to energy production is compromised by Hcit and Orn.
On the other hand, in vivo administration of Hcit and Orn did not change the activities of creatine kinase (CK) and synaptic Na + , K + -ATPase from cerebral cortex of rats, which are important for cell energy buffering and transfer and to keep the neuronal membrane potential necessary for normal neurotransmission, respectively.
Altogether, our present findings indicate that Hcit exerted more significant effects than Orn on most parameters of oxidative stress and bioenergetics here examined, even though it was administered at a lower dose (1.6 μmol) as compared to Orn (5 μmol), reinforcing that Hcit is relatively a more potent neurotoxin. On the other hand, it seems that the mild to moderate disruption of bioenergetics and oxidative damage induced by Orn could hardly be associated with the neurodegeneration of HHH syndrome since this amino acid also accumulates at high amounts in ornithine aminotransferase deficiency, which is characterized by gyrate atrophy of the choroids and retina, with no alteration of the CNS (Javadzadeh and Gharabaghi, 2007; Kaiser-Kupfer et al., 1983; Simell and Takki, 1973) .
At the present we cannot determine the pathophysiological relevance of the present data since to our knowledge brain concentrations of Orn and Hcit are not yet established in HHH syndrome, although blood Orn concentrations may achieve 1 mM during metabolic decompensation in affected patients (Palmieri, 2008; Valle and Simell, 2001 ). However, considering that the present in vivo results are in accordance with previous in vitro findings, showing that Orn and particularly Hcit disturb brain bioenergetics ) and induce oxidative stress , it is presumed that a dual mechanism, energy deprivation and oxidative damage with reduction of tissue antioxidant defenses, secondary to acute accumulation of Hcit and Orn, may contribute to the neurological dysfunction characteristic of HHH syndrome. It should be also noted that during stress situations (for example, episodes of metabolic decompensation) characterized by encephalopathy and intense catabolism and proteolysis, much higher concentrations of these amino acids take place therefore facilitating CNS injury (Camacho et al., 1999) .
Our findings showing bioenergetics impairment and oxidative stress caused by the major compounds accumulating in HHH syndrome may be interrelated since mitochondrial dysfunction is often associated with large increase of reactive species generation because oxidative phosphorylation is the major source of free radicals, which are byproducts of the cell respiratory cycle (Lemasters et al., 1999) . Furthermore, low energy and oxidative damage are key events facilitating the pathogenic cascade leading to necrotic or apoptotic cell death especially in neurons, whose viability highly depends on large amounts of energy to preserve the resting membrane potential (Kroemer and Reed, 2000; Martin et al., 1994) . We cannot also exclude the possibility that creatine deficiency, that occurs in OAT deficiency, may also play a role in the neuropathology of HHH syndrome, but this should be further investigated (Dionisi Vici et al., 1987; Valayannopoulos et al., 2009) .
In summary, the current findings provide insight into possible mechanisms of brain damage in HHH syndrome caused in vivo by Hcit and Orn and indicate that the pathogenesis of this disorder cannot be exclusively attributed to hyperammonemia. Furthermore, the bioenergetics dysfunction caused by Hcit and Orn may explain the mitochondrial abnormalities and the increased urinary excretion of lactate, 2-hydroxyglutyrate, various CAC intermediates and glutaric acid that may be observed in patients with HHH syndrome. Therefore, it is conceivable that, besides a diet poor in proteins that is chronically used, prompt and aggressive treatment of infections with high caloric intake (to reduce the risk of increased catabolism with elevation of brain Orn and Hcit concentrations) and possibly with antioxidants seems justified to avoid aggravation of the brain injury in these patients, especially during acute metabolic decompensation.
4.
Experimental procedures
Reagents
All chemicals were purchased from Sigma Chemical Co., St. Louis, MO, USA, except for [U-
14
C] glucose and [1-14 C] acetate, which were purchased from Amersham International plc, UK and homocitrulline, which was obtained from MP Biomedicals, LLC Solon, Ohio, USA. Ornithine, homocitrulline, Nacetylcysteine, ascorbic acid (vitamin C) and α-tocopherol (vitamin E) were dissolved in saline solution (NaCl 0.9%).
Animals
Thirty-day-old Wistar rats obtained from the Central Animal House of the Departamento de Bioquímica, ICBS, UFRGS, were used in the assays. The animals had free access to water and to a standard commercial chow and were maintained on a 12:12-h light/dark cycle in an air-conditioned constant temperature (22 ± 1°C) colony room. The "Principles of Laboratory Animal Care" (NIH publication no. 80-23, revised 1996) were followed in all experiments and the experimental protocol was approved by the Ethics Committee for Animal Research of the Federal University of Rio Grande do Sul, Porto Alegre, Brazil. All efforts were made to minimize the number of animals used and their suffering.
Intracerebroventricular (ICV) administration
The rats were deeply anesthetized with ketamine plus xilazine (75 and 10 mg/kg, i.p., respectively) and placed on a stereotaxic apparatus. Two small holes were drilled in the skull for microinjection, and 2 μL of a 2.5 M ornithine solution (5 μmol) (pH 7.4 adjusted with NaOH), 0.8 M homocitrulline solution (1.6 μmol) (pH 7.4 adjusted with NaOH) or NaCl (controls) at the same volume and concentration, was slowly injected bilaterally over 4 min into the lateral ventricles via needles connected by a polyethylene tube to a 10-μL Hamilton syringe. The needles (one in each ventricle) were left in place for another 1 min before being softly removed. The coordinates for injections were as follows: 0.6 mm posterior to bregma, 1.1 mm lateral to midline and 3.2 mm ventral from dura (Paxinos and Watson, 1986) . The correct position of the needle was tested by injecting 0.5 μL of methylene blue injection (4% in saline solution) and carrying out histological analysis. In some experiments, the effect of antioxidants on Orn and Hcitinduced oxidative damage was also evaluated by preinjecting the animals daily with N-acetylcysteine (NAC, 150 mg/kg, i.p.), or the combination of α-tocopherol (vitamin E, 40 mg/kg, i.p.) plus ascorbic acid (vitamin C, 100 mg/kg, i.p.), or saline (NaCl 0.9%, i.p.) for 3 days, after which the animals received an acute ICV injection of Orn, Hcit or NaCl.
Cerebral cortex preparation
Animals (male rats) were killed by decapitation 30 min after ICV injection of Orn, Hcit or NaCl, and the brain was immediately removed, the vessels and blood removed, and kept on an iceplate. The olfactory bulb, pons and medulla were discarded and the cerebral cortex was dissected, weighed and kept chilled until homogenization. These procedures lasted up to 3 min. For the determination of oxidative stress parameters, cerebral cortex was homogenized in 10 volumes (1:10, w/v) of 20 mM sodium phosphate buffer, pH 7.4 containing 140 mM KCl. Homogenates were centrifuged at 750 × g for 10 min at 4°C to discard nuclei and cell debris (Evelson et al., 2001 ). The pellet was discarded and the supernatant containing mitochondria was immediately separated and used for the measurements. For CO 2 production, the cerebral cortex was homogenized (1:10, w/v) in Krebs-Ringer bicarbonate buffer, pH 7.4. For the determination of the activities of the respiratory chain complexes I-III, II, II-III and IV and the CAC enzymes, cerebral cortex was homogenized (1:20, w/v) in SETH buffer, pH 7.4 (250 mM sucrose, 2.0 mM EDTA, 10 mM Trizma base and 50 UI mL −1 heparin). The homogenate was centrifuged at 800 × g for 10 min and the supernatant was kept at −70°C until being used for enzymatic activity determination. For creatine kinase activity determination, the cerebral cortex was homogenized (1:10 w/v) in isosmotic saline solution. The period between tissue preparation and measurement of the various parameters was always less than 5 days, except for CO 2 production assays, whose experiments were performed on the same day of the preparations.
4.5.
Preparation of synaptic plasma membrane from rat cerebral cortex
Cerebral cortex was homogenized in 10 volumes of 0.32 mM sucrose solution containing 5.0 mM HEPES and 1.0 mM EDTA. Membranes were prepared according to the method of Jones and Matus (1974) using a discontinuous sucrose density gradient consisting of successive layers of 0.3, 0.8 and 1.0 mM. After centrifugation at 69,000 × g for 2 h, the fraction at the 0.8-1.0 mM sucrose interface was taken as the membrane enzyme preparation.
4.6.
Oxidative stress parameters 4.6.1. Determination of thiobarbituric acid-reactive substances (TBA-RS)
TBA-RS levels were measured according to the method described by Yagi (1998) with slight modifications. Briefly, 200 μL of 10% trichloroacetic acid and 300 μL of 0.67% TBA in 7.1% sodium sulfate were added to 100 μL of tissue supernatant and incubated for 2 h in a boiling water bath. The mixture was allowed to cool on running tap water for 5 min. The resulting pink-stained complex was extracted with 400 μL of butanol. Fluorescence of the organic phase was read at 515 and 553 nm as excitation and emission wavelengths, respectively. Calibration curve was performed using 1,1,3,3-tetramethoxypropane and subjected to the same treatment as supernatants. TBA-RS levels were calculated as nmol TBA-RS/ mg protein.
Determination of sulfhydryl (thiol) content
This assay is based on the reduction of 5,5′-dithio-bis (2-nitrobenzoic acid; DTNB) by thiols, generating a yellow derivative (TNB), whose absorption is measured spectrophotometrically at 412 nm (Aksenov and Markesbery, 2001) . Briefly, 30 μL of 10 mM DTNB and 980 μL of PBS were added to 50 μL of cerebral cortex supernatants. This was followed by 30-min incubation at room temperature in a dark room. Absorption was measured at 412 nm. Results are reported as nmol TNB/mg protein.
Determination of protein carbonyl formation
Protein carbonyl content formation, a marker of oxidized proteins, was measured spectrophotometrically according to Levine et al. (1994) and Reznick and Packer (1994) . One hundred microliters of the aliquots from the incubation was treated with 400 μL of 10 mM 2,4-dinitrophenylhidrazine (DNPH) dissolved in 2.5 N HCl or with 2.5 N HCl (blank control) and left in the dark for 1 h. Samples were then precipitated with 500 μL 20% TCA and centrifuged for 5 min at 10,000 × g. The pellet was then washed with 1 mL ethanol/ethyl acetate (1:1, v/v) and re-dissolved in 550 μL 6 M guanidine prepared in 2.5 N HCl. Then, the tubes were incubated at 37°C for 5 min to assure the complete dissolution of the pellet and the resulting sample was determined at 365 nm. The difference between the DNPH-treated and HCl-treated samples was used to calculate the carbonyl content. The results were calculated as nmol of carbonyls groups/mg of protein, using the extinction coefficient of 22,000 × 106 nmol/mL for aliphatic hydrazones.
Determination of nitrate and nitrite content
Nitrate and nitrite concentrations were determined according to Miranda et al. (2001) . Briefly, 12 μL of 20% trichloroacetic acid was added to 300 μL of cerebral cortex supernatants and centrifuged at 12,000 × g for 10 min. Two hundred microliters of the supernatant was transferred to an eppendorf tube and incubated with 200 μL of 0.8% VCl 3 in 1 M HCl and 200 μL of the Griess reagent (2% sulfanilamide in 5% HCl and 0.1% N-1-(naphtyl)ethylenediamine in H 2 O) at 37°C for 30 min in a dark room. Absorbance was then determined at 540 nm by spectrophotometry. A calibration curve was performed using sodium nitrate. Each curve point was subjected to the same treatment as supernatants and the concentrations were calculated as mmol/mg protein.
Determination of reduced glutathione (GSH) levels
GSH levels were evaluated according to Browne and Armstrong (1998) . Tissue supernatants were diluted in 20 volumes (1:20, v/ v) of 100 mM sodium phosphate buffer pH 8.0, containing 5 mM EDTA. One hundred microliters of this preparation was incubated with an equal volume of o-phthaldialdehyde (1 mg/ mL methanol) at room temperature for 15 min. Fluorescence was measured using excitation and emission wavelengths of 350 and 420 nm, respectively. Calibration curve was performed with standard GSH (0.001-0.1 mM), and GSH concentrations were calculated as nmol/mg protein.
Determination of glutathione peroxidase (GPx) activity
GPx activity was measured according to Wendel (1981) using tert-butylhydroperoxide as substrate. The enzyme activity was determined by monitoring the NADPH disappearance at 340 nm in a medium containing 100 mM potassium phosphate buffer/1 mM ethylenediaminetetraacetic acid, pH 7.7, 2 mM GSH, 0.1 U/mL glutathione reductase, 0.4 mM azide, 0.5 mM tert-butyl-hydroperoxide, 0.1 mM NADPH, and the supernatant containing 0.2-0.4 mg protein/mL. One GPx unit (U) is defined as 1 μmol of NADPH consumed per minute. The specific activity was calculated as U/mg protein.
Determination of catalase (CAT) activity
CAT activity was assayed according to Aebi (1984) by measuring the absorbance decrease at 240 nm in a reaction medium containing 20 mM H 2 O 2 , 0.1% Triton X-100, 10 mM potassium phosphate buffer, pH 7.0, and the supernatants containing 0.05-0.1 mg protein/mL. One unit (U) of the enzyme is defined as 1 μmol of H 2 O 2 consumed per minute. The specific activity was calculated as U/mg protein.
Determination of superoxide dismutase (SOD) activity
SOD activity was assayed according to Marklund (1985) and is based on the capacity of pyrogallol to autoxidize, a process highly dependent on O 2
•− , which is a substrate for SOD. The inhibition of autoxidation of this compound occurs in the presence of SOD, whose activity can be then indirectly assayed spectrophotometrically at 420 nm. The reaction medium contained 50 mM Tris buffer/1 mM ethylenediaminetetraacetic acid, pH 8.2, 80 U/mL catalase, 0.38 mM pyrogallol and supernatants containing 0.1-0.2 mg protein/mL. A calibration curve was performed with purified SOD as standard to calculate the activity of SOD present in the samples. The results are reported as U/mg protein.
4.7.
Energy metabolism parameters 4.7.1. Determination of CO 2 production
Homogenates prepared in Krebs-Ringer bicarbonate buffer, pH 7.4, were added to small flasks (11 cm 3 ) in a volume of 0.45 mL. ), 0.2 mL of 50% trichloroacetic acid was supplemented to the medium and 0.1 mL of benzethonium hydroxide was added to the center of the wells with needles introduced through the rubber stopper. The flasks were left to stand for 30 min to complete CO 2 trapping and then opened. The filter paper were removed and added to vials containing scintillation fluid, and radioactivity was counted (Assis et al., 2004) . Results were calculated as pmol CO 2 h −1 g tissue
.
Spectrophotometric analyses of the activities of citric acid cycle (CAC) enzymes
Citrate synthase activity was measured according to Srere (1969) , by determining DTNB reduction at λ = 412 nm. The activity of the enzyme aconitase was measured according to Morrison (1954) , following the reduction of NADP + at wavelengths of excitation and emission of 340 and 466 nm, respectively. Isocitrate dehydrogenase activity was accessed by the method of Plaut (1969) , by following NAD + reduction at wavelengths of excitation and emission of 340 and 466 nm, respectively. The activity of α-ketoglutarate dehydrogenase complex was evaluated according to Viegas et al. (2009) . The reduction of NAD + was recorded in a Hitachi F-4500 spectrofluorometer at wavelengths of excitation and emission of 340 and 466 nm, respectively. The activity of succinate dehydrogenase was determined as described by Fischer et al. (1985) . Fumarase activity was measured according to O'Hare and Doonan (1985) , measuring the increase of absorbance at λ = 250 nm. Malate dehydrogenase activity was measured according to Kitto (1969) by following the reduction of NADH at wavelengths of excitation and emission of 340 and 466 nm, respectively. The activities of the CAC enzymes were calculated as nmol min −1 mg protein 
Spectrophotometric analysis of the respiratory chain complex I-IV activities
The activities of succinate-2,6-dichloroindophenol (DCIP)-oxidoreductase (complex II) and succinate/cytochrome c oxidoreductase (complex II-III) were determined according to Fischer et al. (1985) . The activity of NADH/cytochrome c oxidoreductase (complex I-III) was assayed according to the method described by Schapira et al. (1990) and that of cytochrome c oxidase (complex IV) according to Rustin et al. (1994) . The methods described to measure these activities were slightly modified, as described in details in a previous report (Silva et al., 2002 
Spectrophotometric analysis of creatine kinase (CK) activity
CK activity was measured according to Hughes (1962) with slight modifications (Schuck et al., 2002) . Briefly, the reaction mixture consisted of 50 mM Tris buffer, pH 7.5, containing 7.0 mM phosphocreatine, 7.5 mM MgSO 4 , and 0.5-1.0 μg protein in a final volume of 0.1 mL. The reaction was then started by addition of 4.0 mM ADP and stopped after 10 min by addition of 0.02 mL of 50 mM p-hydroxy-mercuribenzoic acid. The creatine formed was estimated according to the colorimetric method of Hughes (1962) . The color was developed by the addition of 0.1 mL 20% α-naphtol and 0.1 mL 20% diacetyl in a final volume of 1.0 mL and read after 20 min at λ = 540 nm. Results were calculated as μmol of creatine min was assayed under the same conditions with the addition of 1 mM ouabain. Na + , K + -ATPase activity was calculated by the difference between the two assays (Tsakiris and Deliconstantinos, 1984) . Released inorganic phosphate (Pi) was measured by the method of Chan et al. (1986) . Enzymespecific activities were calculated as nmol Pi released −1 min −1 mg protein.
Protein determination
Protein was measured by the methods of Lowry et al. (1951) using bovine serum albumin as standard.
Statistical analysis
Unless otherwise stated, results are presented as mean ± standard deviation. Assays were performed in duplicate or triplicate and the mean or median was used for statistical analysis. Data was analyzed using one-way analysis of variance (ANOVA) followed by the post-hoc Duncan multiple range test when F was significant. Only significant F values are shown in the text. Differences between groups were rated significant at p < 0.05. All analyses were carried out in an IBMcompatible PC computer using the Statistical Package for the Social Sciences (SPSS) software.
